|
Originally published In Press as doi:10.1074/jbc.M108116200 on January 11, 2002
J. Biol. Chem., Vol. 277, Issue 13, 10938-10948, March 29, 2002
Changes in the Mechanism of DNA Integration in
Vitro Induced by Base Substitutions in the HIV-1 U5 and U3
Terminal Sequences*
Elena
Brin and
Jonathan
Leis
From the Department of Microbiology and Immunology, Northwestern
University School of Medicine, Chicago, Illinois 60611
We have reconstituted concerted human
immunodeficiency virus type 1 (HIV-1) integration with specially
designed mini-donor DNA, a supercoiled plasmid acceptor, purified
bacterial-derived HIV-1 integrase (IN), and host HMG-I(Y) protein
(Hindmarsh, P., Ridky, T., Reeves, R., Andrake, M., Skalka, A. M.,
and Leis, J. (1999) J. Virol. 73, 2994-3003).
Integration in this system is dependent upon the mini donor DNA having
IN recognition sequences at both ends and the reaction products have
all of the features associated with integration of viral DNA in
vivo. Using this system, we explored the relationship between the
HIV-1 U3 and U5 IN recognition sequences by analyzing substrates that
contain either two U3 or two U5 terminal sequences. Both substrates
caused severe defects to integration but with different effects on the
mechanism indicating that the U3 and the U5 sequences are both required
for concerted DNA integration. We have also used the reconstituted
system to compare the mechanism of integration catalyzed by HIV-1 to
that of avian sarcoma virus by analyzing the effect of defined
mutations introduced into U3 or U5 ends of the respective wild type DNA substrates. Despite sequence differences between avian sarcoma virus
and HIV-1 IN and their recognition sequences, the consequences of
analogous base pair substitutions at the same relative positions of the
respective IN recognition sequences were very similar. This highlights
the common mechanism of integration shared by these two different viruses.
*
This work was supported in part by United States Public
Health Service Grant CA38046 and CA52047.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Microbiology
and Immunology, Northwestern University Medical School, 303 E. Chicago Ave., Chicago, IL 60611. Tel.: 312-503-1166; Fax: 312-503-7654; E-mail: j-leis@northwestern.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Chen, I. T. Weber, R. W. Harrison, and J. Leis
Identification of Amino Acids in HIV-1 and Avian Sarcoma Virus Integrase Subsites Required for Specific Recognition of the Long Terminal Repeat Ends
J. Biol. Chem.,
February 17, 2006;
281(7):
4173 - 4182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sinha and D. P. Grandgenett
Recombinant Human Immunodeficiency Virus Type 1 Integrase Exhibits a Capacity for Full-Site Integration In Vitro That Is Comparable to That of Purified Preintegration Complexes from Virus-Infected Cells
J. Virol.,
July 1, 2005;
79(13):
8208 - 8216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gao, R. J. Gorelick, D. G. Johnson, and F. Bushman
Cofactors for Human Immunodeficiency Virus Type 1 cDNA Integration In Vitro
J. Virol.,
December 20, 2002;
77(2):
1598 - 1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Brin and J. Leis
HIV-1 Integrase Interaction with U3 and U5 Terminal Sequences in Vitro Defined Using Substrates with Random Sequences
J. Biol. Chem.,
May 17, 2002;
277(21):
18357 - 18364.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|